Previous Article | Next Article 
Molecular and Cellular Biology, December 1998, p. 6930-6938, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Targeting the Microphthalmia Basic Helix-Loop-Helix-Leucine
Zipper Transcription Factor to a Subset of E-Box Elements In Vitro
and In Vivo
I.
Aksan and
C. R.
Goding*
Eukaryotic Transcription Laboratory, Marie
Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, United
Kingdom
Received 24 June 1998/Returned for modification 29 July
1998/Accepted 4 September 1998
 |
ABSTRACT |
The development of melanocytes, which are pigment-producing cells
responsible for skin, hair, and eye color, is absolutely dependent on
the action of the microphthalmia basic helix-loop-helix-leucine zipper
(bHLH-LZ) transcription factor (Mi); mice lacking a functional Mi
protein are entirely devoid of pigment cells. Mi has been shown to
activate transcription of the tyrosinase,
TRP-1, TRP-2, and QNR-71 genes
through specific E-box elements, most notably the highly
conserved M box. We investigated the mechanism which enables Mi to
be recruited specifically to a restricted subset of E
boxes in target promoters while being prevented from binding E-box
elements in other promoters. We show both in vitro and in vivo that the presence of a T residue flanking a CATGTG E box is an
essential determinant of the ability of Mi to bind DNA, and we
successfully predict that the CATGTG E box from the P gene
would not bind Mi. In contrast, no specific requirement for the
sequences flanking a CACGTG E box was observed, and no
binding to an atypical E box in the c-Kit promoter was
detected. The relevance of these observations to the control
of melanocyte-specific gene expression was highlighted by the
fact that the E-box elements located in the
tyrosinase, TRP-1, TRP-2, and
QNR-71 promoters without exception possess a 5' flanking T residue which is entirely conserved between species as
diverse as man and turtle. The ability of Mi to
discriminate between different E-box motifs provides a mechanism to
restrict the repertoire of genes which are likely to be regulated
by Mi and provides insight into the ability of bHLH-LZ
transcription factors to achieve the specificity required for the
precise coordination of transcription during development.
 |
INTRODUCTION |
The development of an organism
is dependent on a highly specific program of gene
expression coordinated by signal transduction pathways
acting to modulate the activity of transcription factors in response to
environmental signals. A particularly important role is played by cell
type-specific transcription factors, such as Pit-1 and MyoD, that act
as "master regulators" of tissue-specific gene
expression by binding specific elements in their target promoters. These master regulators frequently belong to transcription
factor families which share highly related DNA binding
specificities. Since all cell types will contain multiple members
of these families, and since similar elements will be present in
promoters which are not coordinately regulated, mechanisms to restrict
the repertoire of factors able to bind any given sequence element must
operate. Understanding how such specificity is generated is a major
goal in developmental biology.
Melanocytes, which are pigment cells responsible for skin, hair, and
eye color (34), afford an excellent system for studying the
key events underlying cell type-specific gene expression. Mouse
genetics has identified over 70 different genes which affect the
melanocyte lineage, of which approximately 20 have been cloned. These
include not only the genes involved directly in the genesis of pigment,
such as tyrosinase or tyrosinase-related
protein-1 (TRP-1), but also genes which are necessary
for melanocyte survival or differentiation, including those encoding
the c-Kit (28) and endothelin B (2, 22,
32) receptors or the transcription factors Pax3 (1,
6), Sox10 (31, 36), and microphthalmia (Mi)
(21, 26, 39).
The basic helix-loop-helix-leucine zipper (bHLH-LZ) factor Mi
(21, 26) plays a crucial role in the development of the melanocyte lineage; mice bearing mutations in the
microphthalmia gene completely lack
neural-crest-derived melanocytes (30, 37) and have small eyes due to aberrant formation of the retinal
pigment epithelium (27). In addition, under some
circumstances Mi can convert fibroblasts to cells expressing
melanogenic markers (38). Based on transfection assays, Mi
has been shown to activate the expression of the melanocyte-specific
genes tyrosinase and TRP-1 (3, 14, 19, 42,
44) through an evolutionarily conserved 11-bp sequence
termed the M box (25). The M box contains a core CATGTG
E-box motif recognized by Mi and other members of the bHLH-LZ family of transcription factors.
Since neither tyrosinase nor TRP-1 is essential
for the survival or differentiation of the melanocyte lineage, it is
evident that Mi must target other, as yet uncharacterized genes. Given the significance of Mi as a master regulator of melanocyte
development, the identification of these target genes is a major goal.
However, as Mi is unlikely to regulate all promoters containing
E-box elements, some mechanism must exist to enable Mi to be recruited
specifically to a restricted subset of E boxes in target promoters
while being prevented from binding E-box elements in other promoters.
Understanding how this discrimination is achieved will provide
significant insight into Mi function.
We investigated the mechanism which allows Mi to recognize a specific
subset of CATGTG E-box elements. The results indicate that
the presence of a 5' flanking T residue is a critical determinant of Mi
binding specificity both in vitro and in vivo. The ability of Mi to
discriminate between different E-box motifs provides a mechanism to
restrict the repertoire of genes which are likely to be regulated by Mi
and provides an insight into the ability of bHLH-LZ transcription
factors to achieve the specificity required for the precise
coordination of transcription during development.
 |
MATERIALS AND METHODS |
DNA binding assays.
Standard DNA binding (band shift or
electrophoretic mobility shift) assays were performed essentially as
previously described (29) by using approximately 0.5 ng of
labelled probe and increasing amounts (10, 50, and 250 ng) of
unlabelled competitor oligonucleotide DNA. The full sequence of each
oligonucleotide used is shown in Table 1.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Sequences of oligonucleotides used for DNA binding assays
and as targets in the yeast
CYC-lacZ reportersa
|
|
Yeast manipulations.
Standard methods for yeast culture and
transformation were followed (17). Saccharomyces
cerevisiae W303-1a (a ade2-1 trp1-1 can1-100
leu2-3,112 his3-11,15 ura3) cultures were grown at 30°C in
either YPD (1% yeast extract, 2% glucose, 1% peptone) or in minimal
medium (0.67% yeast-nitrogen base, 1% glucose) supplemented with the
appropriate amino acids (0.002%) as required.
-Galactosidase activity was assayed as described previously (20).
Yeast expression and reporter vectors.
Mi cDNAs encoding the
(+) or (
) forms of the protein were inserted as BglII
fragments into the unique BglII cloning site of the
high-copy plasmid pKV701.VP16 and the low-copy plasmid pRS315KV, which
are located between the GAL10 promoter and PGK terminator.
In pKV701.VP16, the Mi protein is expressed with the VP16 transcription
activation domain fused to the N terminus. The construction of the
pRS315KV and pKV701.VP16 expression vectors has been described
previously (20, 23), as have the Myc and Max expression
vectors (7, 10). The lacZ reporter plasmids are
based on pLSLS.CYC described by Crouch et al. (7). This plasmid contains a basal CYC promoter in which the two
CATGTG E-box motifs have been mutated. Oligonucleotides
containing specific sequence elements were inserted into a unique
BglII cloning site located 5' to the basal CYC
promoter. The full sequences of the oligonucleotides used, each of
which contains a duplicated element, are shown in Table 1.
Bacterial expression of MITF.
The glutathione
S-transferase (GST)-Mi transcription factor (MITF) fusion
protein expression vector, pGEX-MITF (43), was a gift from
S. Shibahara. To produce purified GST fusion proteins, 20 to 40 ml of
an overnight culture of BL21(DE3) pLysS cells containing a GST fusion
protein vector was diluted 1:10 with Luria broth containing 100 µg of
ampicillin/ml and cultured in a rotary shaker until the optical density
at 600 nm reached 0.2 to 0.4. The expression of the GST-MITF fusion
protein was induced for 4 h by the addition of IPTG
(isopropyl-
-D-thiogalactopyranoside) to the culture to a
final concentration of 200 µM. Cells were harvested by centrifugation at 5,000 to 7,000 rpm for 10 min at 4°C. The resultant pellet was
resuspended in 2 to 5 ml of ice-cold NET buffer (10 mM Tris-HCl [pH
8.0], 1 mM EDTA, 100 mM NaCl) and 1× proteinase inhibitor cocktail
(Boehringer Mannheim), frozen on dry ice for 5 to 20 min, thawed on
ice, and DNaseI treated on ice for 2 to 3 h. The supernatant was
clarified by centrifugation at 4°C, mixed with 100 to 300 µl of
glutathione Sepharose-4B beads (pre-equilibrated with NET buffer)
(Pharmacia), and incubated at 4°C for 20 min on a roller. The beads
were then washed three to four times with NET buffer and stored as a
50% slurry at 4°C in the presence of 0.1% thimerosal as a
preservative. GST fusion protein was then eluted from the Sepharose-4B
glutathione beads by first washing the beads once with 2 volumes of a
mixture of 50 mM Tris-HCl (pH 8.0), 10 mM MgSO4, and 2 mM
ATP for 30 min at room temperature. The beads were pelleted by
centrifugation at room temperature and washed once with 2 volumes of a
mixture of 100 mM Tris-HCl [pH 8.0], 120 mM NaCl, and 0.2% Triton
X-100 for 30 min at room temperature and pelleted as described above.
The bound protein was then serially eluted off the beads into 2 volumes
of a mixture of 100 mM Tris-HCl [pH 8.0], 120 mM NaCl, 0.2% Triton
X-100, and 25 mM glutathione. The protein concentration was then
calculated by comparing against a bovine serum albumin standard on a
Coomassie-stained sodium dodecyl sulfate-polyacrylamide gel. MITF
protein was then purified from the GST-MITF bound to Sepharose-4B
glutathione beads by means of thrombin cleavage (Sigma). Protein-bead
complexes were washed once with 5 volumes of a mixture of 50 mM
Tris-HCl [pH 7.4], 10 mM MgSO4, and 2 mM ATP, once with 5 volumes of a mixture of 100 mM Tris-HCl [pH 8.0], 120 mM NaCl, and
0.2% Triton X-100, and once with 5 volumes of thrombin buffer (50 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM MgCl2, 2.5 mM
CaCl2, 1 mM dithiothreitol). The fusion protein was cleaved
by incubating overnight at 4°C in 0.5 to 2 volumes of thrombin buffer
and 5 to 20 U of thrombin. The beads were then pelleted, and the
supernatant was transferred to a new tube and stored at 4°C.
Thrombin-cleaved human MITF protein had a usable shelf life of 3 to 4 days at 4°C for bandshift reactions. Both thrombin-cleaved- and
GST-MITF fusion proteins bound DNA with the same specificity, though in
general binding by the GST fusion protein was more readily observed.
Expression of USF-1.
The plasmid pT7Link.USF-1 (a gift from
M.-D. Galibert) contains a USF-1 cDNA under the control
of the T7 promoter and was transcribed and translated in vitro using
rabbit reticulocyte lysate (Promega) in accordance with the
manufacturer's instructions. Reactions were incubated at 30°C for
1 h and used immediately for the DNA binding assays.
 |
RESULTS |
Mi discriminates between CATGTG E-box motifs.
Mi
plays an essential but poorly characterized role in melanocyte
development. Although it can regulate tyrosinase and
TRP-1 expression, it must also control the expression of
genes involved in survival or proliferation of the melanocyte lineage.
The identity of these genes is presently unknown, but since Mi is a
member of the bHLH-LZ transcription factor family, it is likely that any Mi target gene will be regulated by E-box elements with the generic
sequence CANNTG. Since Mi shares a related DNA binding domain with c-Myc and its dimerization partner Max, we
initially considered the possibility that Mi and the Myc-Max
heterodimer might regulate similar genes. It is known for example
that Myc can regulate genes involved in both proliferation and
apoptosis. One recently identified Myc target gene is that encoding the
CDC25a phosphatase (12); up-regulation of cdc25a
expression by Myc appears to correlate with the induction of apoptosis.
Examination of the three E-box elements recognized by Myc (MB1, MB2,
and MB3) located in the first and second introns of the
cdc25a phosphatase gene, revealed that the MB2 element
shares 10 of 11 bp with the known Mi target, the M box, which is
conserved in all melanocyte-specific promoters analyzed to date. The
striking similarity between MB2 and the M box strongly suggested that
MB2, like the M box, would be a target for Mi. The sequence alignment
between the 11-bp M box and the MB1, MB2, and MB3 elements from the
cdc25a phosphatase gene is shown in Fig.
1A.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Mi discriminates between highly related E-box
motifs. (A) E-box motifs used as probes and competitors. Only the E-box
and flanking sequences are shown. The full sequence of each
oligonucleotide is given in Table 1. (B) DNA-binding band shift
(electrophoretic mobility shift) assay using bacterially expressed and
purified Mi together with the M-box probe and the indicated competitor
oligonucleotides at 10, 50, and 250 ng. Only the bound DNA is shown.
(C) DNA-binding assay using in vitro transcribed and translated Mi and
the M-box probe and indicated oligonucleotide competitors at 10, 50, and 250 ng. (D) Yeast one-hybrid assay using a CYC-lacZ
reporter containing the indicated target elements, cotransformed with a
vector expressing Mi(+) fused to the VP16 activation domain. (E) As for
panel D but using a VP16-Mi( ) expression vector. (F) Yeast assay for
activity of native Myc and Max proteins on the indicated
CYC-lacZ-based reporters. Myc and Max were coexpressed in
yeast with activation of transcription by Myc being absolutely
dependent on Max expression, while Max alone does not activate
transcription in this assay (not shown). Residue substitutions are
indicated by "greater than" symbols. For example, T>A indicates a
T-to-A substitution.
|
|
To determine whether Mi could bind the Myc binding sites from the
cdc25a phosphatase gene, we performed a band shift assay using a radiolabelled M-box probe and competed for Mi binding by using
either the M box or the MB1, MB2, or MB3 element. The results (Fig. 1B)
obtained were surprising in two respects. First, although a CATGTG
E-box element was present in both the M box and the MB1
element, no Mi binding to MB1 was observed. Second, the MB2 element
bound Mi, but at least fivefold to 10-fold less efficiently than the M
box, despite the fact that 10 of 11 bases are conserved between the two
elements. In contrast, binding to MB3, which contains a CACGTG
E box, was as efficient as binding to the M box. Thus,
remarkably, Mi was able to discriminate between the M box and the MB1
and MB2 elements even though all three contained a CATGTG
E-box motif. One clue as to the origin of the ability of Mi to
distinguish between related E boxes lies in the fact that within the
core binding sequence, the M box and MB2 differ only by a T-to-A
transversion at position
4 relative to the center of the conserved
CATGTG E box. It was possible therefore that this base
played a key role in the ability of Mi to distinguish between these two
sequences, particularly since the MB1 element which fails to bind Mi
also differed from the M box at this position. However, since the MB3
CACGTG element bound Mi well but did not contain a T residue
at the
4 position, it was also possible that the influence of
specific flanking sequences was restricted to a CATGTG-type
E-box element.
To test this possibility, we designed specific competitors in which the
T residue at the
4 position of the M box was replaced with an A or in
which the A residue in the equivalent position in MB2 was replaced with
T. These mutated oligonucleotides (Fig. 1A) were also used as
competitors in the band shift assay using the M-box probe. The results
(Fig. 1B) demonstrate that the single A-to-T substitution in the MB2
element is sufficient to allow binding by Mi to a level equivalent to
that of a wild-type (WT) M box. Similarly, Mi binding is reduced
approximately fivefold to 10-fold using the M box T-to-A competitor.
Thus, the presence of a T residue at the
4 position is a key
determinant in the ability of Mi to distinguish between an M box and
the MB2 site in vitro.
To investigate more systematically the requirement for the flanking
residue, we also replaced the T present in the M box with either a C or
a G and compared binding to that achieved using a WT M box or the M box
T-to-A competitor. The results shown in Fig. 1C demonstrate that Mi was
able to recognize efficiently only the WT M box and that replacement of
the 5' flanking T residue with either A, C, or G severely inhibited binding.
The results described above suggest that flanking sequences may
determine whether Mi can bind a specific E-box element. However, these
results were obtained in vitro, and it was possible that in vivo, the
presence or absence of a 5' T residue would play a less significant
role. To determine whether the Mi could discriminate between different
E-box elements in vivo, we made use of a yeast one-hybrid assay in
which Mi was expressed as a VP16 activation domain-tagged protein, and
its ability to activate reporters comprising specific E-box motifs
upstream of a basal CYC-LacZ reporter was assessed. We have
successfully used this assay previously to reconstitute Max-dependent
transcription activation by Myc and to characterize the in vivo binding
specificity of the Myc-Max complex (7, 10). Moreover, the
yeast assay enables the binding specificity of Mi homodimers to be
assessed in the absence any background generated by any other bHLH-LZ
factors which may bind the M box or related sequences in mammalian cells.
Using an M-box reporter, expression of the VP16-tagged Mi resulted in
efficient transcription activation (Fig. 1D). Using either an empty
expression vector (not shown) or a reporter lacking an M box, no
activation was observed, indicating that the activity of the M-box
reporter was entirely dependent on both Mi and an appropriate
Mi-binding site. In contrast, the MB2 reporter was essentially inactive
both in the presence or absence of Mi, suggesting that the effect of
the T residue at position
4 was even more critical in vivo than in
vitro. Consistent with the results obtained in vitro, mutation of the
5' flanking A residue present in the MB2 sequence to the T present in
the M box enabled Mi to activate transcription from this sequence.
Similar results were obtained using a non-VP16-tagged Mi (not shown),
though activation of transcription was reduced and as such the assay
was less sensitive.
The Mi protein exists in two forms, termed Mi(
) and Mi(+), which
differ by an internal six amino acids resulting from the expression of
a differentially spliced mRNA (20). The results described
above were obtained by expression of the Mi(+) form of the protein.
Given that it has been reported that the presence of these additional
six amino acids may alter the DNA binding specificity of Mi
(19), it was important to compare the ability of the Mi(+)
or Mi(
) proteins to recognize the M-box and MB2 elements
differentially. The result, shown in Fig. 1E, indicates that the Mi(
)
protein activates an M box approximately three- to fourfold less well
than the Mi(+) protein (compare activity to that shown in Fig. 1D),
which is consistent with the lower level of activation by Mi(
)
observed in mammalian cells (33). Nevertheless, as for the
Mi(+) protein, Mi(
) was unable to activate transcription from the MB2
element but could bind an MB2 site in which the flanking A residue was
changed to T (as in the M box). No activation was observed by
expression of either protein by using an MB2 reporter. Thus the ability
of Mi(+) and Mi(
) to discriminate between the M-box and MB2 elements
was essentially indistinguishable.
To demonstrate that although the MB2 element was not targeted by
Mi, it was nevertheless functional, we asked whether it
could be activated by Myc-Max in yeast, as it had previously been
reported to be a Myc-Max target element in mammalian cells. We have
shown previously that activation by Myc in yeast is entirely dependent on Max, and that expression of either protein alone fails to activate transcription (7). To assay for the ability of Myc-Max to
bind and activate transcription from the MB2 and M-box elements,
vectors expressing both Myc and Max were introduced into yeast together with either the M-box or MB2 reporters, and the resulting levels of
-galactosidase activity were determined. The results are shown in
Fig. 1F. In the absence of Myc-Max expression, no
-galactosidase activity from either reporter was detected (not shown). In contrast, expression of Myc-Max resulted in activation of both the M-box and MB2
reporters. No activation was observed using a reporter lacking either
the M-box or MB2 element. This result is significant in two respects:
first, it confirms that while the MB2 element cannot be activated by
Mi, it is nevertheless fully competent to support transcription
activation directed by the Myc-Max heterodimer; and second, the T
residue flanking the CATGTG motif of the M box does not
inhibit activation by the Myc-Max heterodimer. This was surprising
since it had been shown previously that the ability of Myc-Max to bind
a CACGTG E box is inhibited substantially by the presence of
a 5' T residue at the
4 position both in yeast and in mammalian cells
(10, 35). Clearly, the inhibitory effect of the T residue on
Myc-Max binding does not apply in the case of CATGTG E-box elements.
Conservation of specificity between melanocyte-specific E-box
elements.
The data obtained so far strongly suggest that in vivo,
the presence of a T residue immediately 5' to the CATGTG
motif is essential for DNA binding by either Mi(+) or Mi(
).
Although the M box evidently represents a good target for Mi both in
yeast and in mammalian cells, several other E-box elements present in melanocyte-specific promoters are known to be targets for Mi in mammalian transfection assays. If the presence of a 5' flanking T
residue were important, it might be expected that these E boxes would
also contain a T at the
4 position and that the T residue would be
conserved between species. We therefore aligned the E-box motifs from
the M box, the initiator E box and the tyrosinase distal enhancer (TDE)
E box identified in tyrosinase promoters from different
species, as well as the TRP-1 and TRP-2 M-box
elements and the E-box motifs from the quail QNR71 gene
promoter (Fig. 2). Strikingly, the 5'
flanking T residue was present in the M box from the human, mouse,
quail, and turtle tyrosinase genes as well as in the M-box
motifs derived from the TRP-1 and TRP-2 genes.
Similarly, a T residue at the
4 position was also present in the TDE
from all four species, the TDE also being flanked on the 3' side by a
conserved A residue and being opposite a T on the bottom strand. At the
tyrosinase initiator, no T residue was present on the 5'
4 position,
but the CATGTG E box did possess a conserved 3' A residue
opposite a T at the
4 position on the bottom strand. The striking
conservation of the flanking T residues was also apparent in the
QNR-71 gene promoter where both E-box elements, which are
known targets for Mi (41), also conform to the consensus for
binding by Mi. It is also satisfying that both E-box motifs in the
QNR-71 promoter have also been shown to be Myc responsive
(41), given that the yeast assays revealed that an M box can
be regulated by the Myc-Max heterodimer.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Conservation of the E-box motifs within
melanocyte-specific promoters and between species. The
tyrosinase promoter contains three Mi-responsive CATGTG
E-box motifs termed the TDE, the M box, and the initiator E box.
All three elements from all four species possess a 5' flanking T
residue (boxed) at the 4 position on either the top strand (M box)
the bottom strand (initiator E box) or both strands (TDE). The
conservation of the 5' flanking T residue is also seen in the
Mi-responsive elements from the quail QNR71 promoter as well
as in the TRP-1 M box, and the M box and upstream E box from
the TRP-2 promoter. The numbers indicate the positions of
the sequences shown relative to the transcription start sites in the
cognate promoters.
|
|
Taken together with the binding studies on the M-box and MB2 elements,
the absolute conservation of a T residue flanking all E-box elements
known to be targets for Mi strongly suggests that the presence of a T
in this position enables Mi to discriminate between different E-box
motifs in melanocytes. To test this further, we performed band shift
assays using the M-box probe and WT or mutant competitors derived from
the tyrosinase initiator or TDE (Fig. 3A
and C). The results demonstrate that the efficiency of Mi binding to a
CATGTG element correlates precisely with the presence of a
5' T residue flanking the E box. Thus, a WT TDE, which contains a 5'
flanking T residue at the
4 position on both strands, competes for Mi
binding approximately threefold better than an M box (Fig. 3B).
Mutation of either T residue flanking the TDE to A or G, mutants m1 and
m2, respectively, resulted in decreased DNA binding by Mi to a level
seen using an M-box competitor. In contrast, a double mutant, m3, in
which both flanking T residues are mutated, failed to bind Mi.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Mi binding to the TDE and initiator (Inr) require the
presence of a 5' flanking T residue. (A, C) E-box motifs used for
probes and competitors in the DNA binding band shift assays (for
complete sequences see Table 1). (B, D) Band shift assays using an
M-box probe and indicated WT and mutant competitors at 10, 50, and 250 ng. Competitors were derived from the mouse TRP-1 M box, the
human tyrosinase TDE (hTyros TDE), and the human and mouse
initiator elements (hTyros InrE and mTyros InrE, respectively). Only
the bound DNA is shown.
|
|
A similar pattern was observed using the tyrosinase initiator E-box
sequence (Fig. 3D). Both the human and mouse initiator elements
competed for Mi binding to the M box probe as well as the M box itself,
whereas mutation of the T residue at the
4 position flanking the
initiator E box on the bottom strand abolished its ability to bind Mi.
In summary, the data obtained using the M box, TDE, and initiator all
point to a requirement for a T residue located at the
4 position of a
CATGTG E box if Mi is to bind DNA efficiently.
The MB3 element contains a CACGTG E box and binds Mi
efficiently. To determine whether this was a peculiarity of the MB3
sequence or whether Mi could also bind CACGTG motifs found
in other promoters, band shift assays using the M box probe together
with E-box elements derived from the adenovirus major-late promoter, as
well as the p53 and cyclin B1 promoters as competitors were performed.
The results obtained (not shown) indicated that all the CACGTG
E-box elements used were able to bind Mi, which is consistent
with the previous observation that Mi could bind the CACGTG
element in the adenovirus major-late promoter (19).
Mi does not bind the CATGTG E box in the P-gene
promoter.
Since the tyrosinase, TRP-1,
TRP-2, and QNR-71 promoters all contain Mi
binding sites, it might be expected that this would be true for the
promoters from other genes involved in melanogenesis. Mutations in the
P gene, encoded by the pink-eyed dilution locus (15), result
in oculocutaneous albinism, and the P gene itself is thought to encode
a tyrosine transporter. The role of the P gene in melanogenesis,
together with the fact that its promoter contains a CATGTG E
box (24), has led to speculation that it too is regulated by
the MITF. However, examination of the P-gene E box indicates that the
CATGTG motif does not possess the critical flanking T
residue (Fig. 4A) found to be essential
for binding to the E-box elements in the tyrosinase,
TRP-1, TRP-2, and QNR-71 promoters. On
the basis of the experiments described above, we would predict that
this element would not in fact bind Mi. To test this, we performed a
band shift assay using an M-box probe and either the M-box or the
P-gene element as competitors. The result (Fig. 4B) indicates that
while the M box binds Mi efficiently, the P-gene CATGTG E
box does not. Thus, the lessons learned from the analysis of Mi binding
specificity on the tyrosinase and TRP-1 promoter
elements enable accurate predictions to be made as to which E-box
motifs are likely to be recognized by Mi.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
Mi does not bind the E-box element in the P gene. (A)
Oligonucleotides used as probes or competitors in the DNA binding band
shift assay. Full sequences are given in Table 1. (B) Band shift assay
using the M box probe and indicated competitors at 10, 50, and 250 ng.
Only bound DNA is shown.
|
|
USF-1 binding specificity.
When the M box and tyrosinase
initiator E box were first identified, DNA binding assays using
melanoma cell nuclear extracts identified USF-1 as the predominant
factor competent to bind these sequences in vitro (3, 25).
Although subsequently modification of the assay conditions allowed the
detection of Mi DNA-binding activity in similar nuclear extracts
(5), it seems likely that both factors may be competent to
bind the E-box motifs present in the melanocyte-specific
promoters. Given the specificity of Mi binding to these
elements, we also wished to determine whether DNA recognition by USF-1
was similar to or different from that of Mi. Understanding the precise
requirements for USF-1 binding might provide clues as to whether Mi and
USF-1 were likely to compete for binding in vivo. To this end,
in vitro transcribed or translated USF-1 was used in a band shift assay
together with an M-box probe and WT or mutant M box, or MB2
competitors. The results (Fig. 5)
revealed that USF-1 possessed a remarkably similar binding specificity
to Mi. In other words, USF-1 bound an MB2 element around fivefold less
well than the M box, while mutating the 5' flanking A residue to a
T in MB2, or the 5' flanking T residue in the M box to A, resulted in a
fivefold increase or decrease in USF-1 binding, respectively. In
addition, alteration of the CATGTG sequence at the core of
the M box to CACGTG enabled USF-1 to bind this sequence at
least fivefold to 10-fold better than the WT M box. These data suggest
that Mi and USF might well compete for binding to melanocyte-specific
promoters in vivo.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Efficient binding by USF-1 to a CATGTG E box
requires a 5' flanking T residue. (A) WT and mutant oligonucleotides
used as probes and competitors. (B) In vitro transcribed-translated
USF-1 was used in DNA binding band shift assay using an M-box probe and
the indicated competitors at 10, 50, and 250 ng. Unprogrammed
reticulocyte lysate was used as a control and the complex formed using
the programmed lysate is supershifted by the addition of anti-USF-1
antibody. Only the bound DNA is shown.
|
|
We also attempted to use a VP16-USF chimera in a yeast one-hybrid assay
to compare USF DNA binding specificity in vivo to that of Mi.
Interestingly, using this assay, we were unable to observe any
activation of E-box reporters, including the E box from the adenovirus
major-late promoter, by the VP16-USF protein. Since the ability of USF
to bind DNA in vivo appears to be regulated by phosphorylation
(13), it is possible that the specific signal transduction
pathway required for USF to bind DNA efficiently in vivo does not
operate in yeast.
Mi homodimers do not bind an atypical E box in the
c-Kit promoter.
The results described above would
indicate that Mi recognizes either a CACGTG E box or a
highly specific subset of CATGTG E-box elements. However, a
previous report (40) suggested that Mi may also bind an
atypical E-box element, (CACGTGCCAGGTG) in the promoter for
the c-Kit gene. Although it has recently been demonstrated
that Mi is phosphorylated by mitogen-activated protein kinase in
response to signalling via the c-Kit receptor tyrosine kinase (18), the ability of Mi to activate the gene encoding the receptor would provide a potential regulatory feedback loop. The
ability of Mi to bind the c-Kit element would clearly
increase the repertoire of genes which were likely candidates for
regulation by Mi. In an attempt to understand better the ability of Mi
to recognize this atypical E box and to identify which residues were required for Mi binding, we performed an initial band shift assay using
the M-box probe and the c-Kit or M-box competitors.
Surprisingly, under conditions where binding to the M box was readily
apparent, we were unable to observe any binding by Mi to the
c-Kit element (Fig. 6A and B).
In the event that our inability to detect Mi binding to the
c-Kit element was an artifact of our in vitro binding conditions, we also considered whether Mi could activate the atypical c-Kit E-box motif in the yeast one-hybrid assay. The
c-Kit element was therefore cloned upstream from the
CYC-LacZ reporter and its responsiveness to Mi compared to
that of the M box. Consistent with the results of our in vitro binding
assays, while Mi was able to active efficiently the M-box reporter,
using either the Mi(+) (Fig. 6C) or Mi(
) (not shown) proteins, no
activation from the c-Kit reporter was observed. The
c-Kit E box was nevertheless functional since it was
activated weakly though specifically by the bHLH factor MyoD (Fig. 6D),
which failed to activate transcription via the M box. We conclude that
under the conditions used here, Mi does not recognize the
c-Kit sequence.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
The atypical E-box elements in the c-Kit
promoter do not bind Mi. (A) Oligonucleotides used as probe and
competitors in the DNA binding assay. (B) Band shift assay using an
M-box probe and bacterially expressed and purified Mi together with the
indicated competitors at 10, 50, and 250 ng. (C) Yeast one-hybrid assay
for binding of VP16 Mi to the M box and c-Kit E-box
elements. (D) Yeast one-hybrid assay for binding of MyoD to the M box
and c-Kit E-box elements. Yeast were transformed with the
indicated CYC-lacZ reporters together with vectors
expressing either an Mi-VP16 fusion protein or MyoD were assayed for
-galactosidase activity. The sequences of the oligonucleotides
cloned into CYC-lacZ reporter plasmids are listed in Table
1.
|
|
 |
DISCUSSION |
Mi plays an essential but largely uncharacterized role in the
development of the melanocyte lineage. Mi must therefore regulate genes
required for the survival or maintenance of melanoblasts following
their commitment to the melanocyte lineage. However, to date, the only
genes which have been identified as targets for Mi are those such as
tyrosinase, TRP-1, and TRP-2 which
encode melanogenic enzymes and which, while playing a critical role in pigmentation, do not exert any influence on the survival or maintenance of the melanocyte lineage. The identity of the genes through which Mi
mediates its developmental function is unknown, but presumably they are
regulated by specific E-box elements. Given that any cell may contain
multiple bHLH-LZ transcription factors each able to recognize an E-box
motif, mechanisms must operate to preserve the specificity required to
maintain the complex program of gene expression underlying development.
This is as true for other cell types as it is for the melanocyte.
In attempting to understand the nature of these Mi-regulated genes,
we initially considered that Mi might regulate at least a subset of
those genes which are targets for the Myc-Max heterodimer. The
cdc25A phosphatase gene appeared at first sight a
particularly attractive candidate since Myc-Max was shown previously to
regulate its expression via three E-box elements (12), one
of which, MB2, exhibited a striking degree of identity to the known Mi
target, the M box. However, in vitro binding assays established that in contrast to our expectations, Mi was unable to bind the MB1 element in
vitro and bound MB2 poorly, despite the similarity to the M box, a
result confirmed by using the yeast one-hybrid assay. Additional DNA
binding assays demonstrated that the ability of Mi to discriminate between different CATGTG E-box elements was dictated by the
nature of the base at position
4 relative to the center of the E box. For Mi to bind efficiently, the
4 position should be occupied by a T
residue; that is, Mi will bind either TCATGTG, CATGTGA, or preferably TCATGTGA. Since a C in the
4 position
does not allow binding by Mi, we presume that Mi makes a specific
contact in the major groove with the methyl group present on a T
residue. However, it is very difficult to say with any precision,
since the basic regions of the bHLH and bHLH-LZ factors appear to
recognize DNA in subtly different ways. The only positive clue to
the requirement comes from the fact that in the USF crystal structure
(9), Val8 in the basic region (the conserved Glu is at
position 9) makes a van der Waals contact with a flanking T base. Since
M contains an isoleucine in this position, it is possible that
this residue makes a similar contact with the 5' flanking T residue.
The results from our in vitro binding assays and the yeast one-hybrid
assay suggesting that the ability of Mi to discriminate between
CATGTG E boxes was determined by the presence or absence of
a T residue at the
4 position were further substantiated by the
alignment between all the E-box elements present in the promoters of
the tyrosinase, TRP-1, TRP-2, and
QNR-71 genes. In every case, the core CATGTG
E-box motifs were flanked by a T residue at the
4 position. We
went on to show that for both the initiator and the TDE, the presence
of the T residue in this position was an essential determinant for M
binding. The significance of this observation was underscored by the
fact that for the tyrosinase promoter, the 5' flanking T
residue is entirely conserved between species as divergent as human and
turtle, and that a second CATGTG E box in the tyrosinase
enhancer, described by Yasumoto et al. (42), does not
possess a T residue at the
4 position and is not responsive to
Mi. Taken together, these observations strongly suggest that the
ability of Mi to discriminate between different CATGTG E-box
elements is dictated by the nature of the base at position
4 in vivo.
One distinct advantage to the cell would be the fact that the ability
of Mi to discriminate between different CATGTG E boxes
would inevitably restrict the repertoire of E-box-containing genes
regulated by Mi. Indeed, the absence of a flanking T residue adjacent
to the CATGTG element in the P-gene promoter led us to predict accurately that this element would not be recognized by Mi.
Although our results clearly demonstrate that Mi can distinguish
between different CATGTG E-box motifs, Mi appears to
recognize CACGTG E boxes relatively indiscriminately. This
raises an intriguing question, namely, if the tyrosinase,
TRP-1, TRP-2, and QNR-71 promoters are
regulated by Mi, why do their promoters not contain CACGTG
E-box elements? Several explanations are plausible. It is
possible, for example, that in vivo, E-box elements are recognized by
different bHLH-LZ transcription factors at different times. The choice
of which bHLH-LZ factor will be bound at any given time will be
dictated by several factors including the relative abundance of each
factor and whether their ability to bind DNA either alone or in
cooperation with other transcription factors is regulated by specific
signal transduction pathways. It is already known, for example, that
the M-box and initiator E-box elements from the tyrosinase
promoter are recognized both by Mi and by USF (3, 25, 42).
DNA binding by USF appears to be regulated (13), as is the
abundance of Mi whose expression is transiently increased by
elevated cyclic AMP levels (4). Thus, in vivo, the various
E-box elements in the tyrosinase and other promoters may
under appropriate conditions exchange USF and Mi, and a high-affinity binding site for USF, such as a CACGTG-type E box, may
hinder such an exchange.
Along the same lines, it is also possible that in vivo, CACGTG
elements are simply not accessible to Mi owing to the presence of
other bHLH-LZ factors able to recognize this sequence.
Consequently the CATGTG elements found in the
melanocyte-specific promoters may be recognized by a more
restricted subset of bHLH-LZ factors with which Mi is better able to
compete. In yeast for example, neither the bHLH factor Pho4 nor the
bHLH-LZ factor Cpf1 are able to bind CATGTG E-box elements
but will bind CACGTG motifs (16). Interestingly,
the ability of Pho4 to bind a CACGTG E box is strongly inhibited by a T residue at the
4 position, while binding by Cpf1 is not (11). Similarly, binding by Myc-Max
heterodimers, but not by Max-Max homodimers, is also inhibited by
a T residue flanking a CACGTG motif in yeast and
mammalian cells (10, 35), though as we have demonstrated
here, this rule does not apply on a CATGTG E box.
Nevertheless, the ability of bHLH-LZ factors to discriminate between
different E-box motifs based on the nature of the 5' flanking base
appears to represent a common theme that is likely to underpin much of
the specificity required for undertaking the program of gene expression
mediated by bHLH-LZ factors during development.
In addition to these considerations, it is also possible that a
CATGTG E box may contribute to binding other,
non-bHLH-LZ factors. In this respect it has not escaped our
attention that the 5' half of an M box, 5'-AGTCAT may on the
other strand represent a half site for members of the AP1
transcription factor families, with the T residue at the
4
position being at the core of this potential binding site. Whether the
M box is in reality targeted by any of these factors acting alone
or in conjunction with Mi is not currently known.
Of course, one criticism of the experiments which we have described
here might be that the binding specificity of Mi both in vitro and in
the yeast one-hybrid assays has been determined using Mi homodimers and
that in vivo, DNA recognition by any Mi heterodimer might be different.
Indeed, in vitro, Mi can bind DNA as a heterodimer with the bHLH-LZ
transcription factors TFE3, TFEB, and TFEC (19). However, at
the earliest times in the melanocyte lineage, when Mi function is
clearly critical, there is no evidence that TFEB or TFE3 is expressed
in these cells (27). Of course, we cannot rule out a role
for Mi heterodimers later in melanocyte development. However, it is
clear from the results of many studies on a variety of bHLH-LZ
factors that DNA binding specificity is dictated by the basic
region. The basic regions of TFE3, TFEB, and TFEC are
identical to that of Mi and, although we have not examined this
directly, we would not expect the binding specificity of any Mi
heterodimer to be different from that of a Mi homodimer.
Finally, in contrast to previous work (40), we were unable
to detect binding by Mi to the atypical E-box motif present in the
c-Kit promoter either in vitro or in the yeast one-hybrid assay. Since our assay was performed under conditions where the M box
was clearly recognized, the previous report of the interaction between
Mi and this element may reflect the particular binding conditions used
by those authors. That is not to say that these sequences do not act to
regulate c-Kit expression in cells but simply that, in our
view, they are unlikely to act as a target for Mi homodimers. Neither
do we wish to imply that Mi cannot regulate the c-Kit
promoter; regulation of c-Kit expression seems to be
complex, with DNA rearrangements up to 100 kb away appearing to affect
the activity of the c-Kit gene (8), and as such
we cannot rule out any effect of Mi elsewhere in the sequences flanking the c-Kit gene.
In summary, we have provided for the first time a mechanism to explain
how transcription activation by microphthalmia may be restricted to a
specific subset of target genes. The insight gained from
this work should prove invaluable in the search for genes other than
tyrosinase, TRP-1, TRP-2, and
QNR71 which are regulated by Mi. Moreover, although we have
restricted our studies to Mi and the melanocyte lineage, it is likely
that similar mechanisms operate to facilitate discrimination between
different E-box elements by other members of the bHLH-LZ family of
transcription factors in other cell types.
 |
ACKNOWLEDGMENTS |
We thank Ugur Yavuzer for performing the initial yeast one-hybrid
assays, S. Shibahara for providing the GST-MITF expression vector, and
Don Ayer for the yeast MyoD expression vector.
This work was supported by the Association for International Cancer
Research and Marie Curie Cancer Care.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Eukaryotic
Transcription Laboratory, Marie Curie Research Institute, The Chart,
Oxted, Surrey RH8 0TL, United Kingdom. Phone: (44) 1883 722306. Fax: (44) 1883 714375. E-mail: c.goding{at}mcri.ac.uk.
 |
REFERENCES |
| 1.
|
Baldwin, C. T.,
N. R. Lipsky,
C. F. Hoth,
T. Cohen,
W. Mamuya, and A. Milunsky.
1994.
Mutations in PAX3 associated with Waardenburg syndrome type I.
Hum. Mutat.
3:205-211[Medline].
|
| 2.
|
Baynash, A. G.,
K. Hosoda,
A. Giaid,
J. A. Richardson,
N. Emoto,
R. E. Hammer, and M. Yanagisawa.
1994.
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons.
Cell
79:1277-1285[Medline].
|
| 3.
|
Bentley, N. J.,
T. Eisen, and C. R. Goding.
1994.
Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator.
Mol. Cell. Biol.
14:7996-8006[Abstract/Free Full Text].
|
| 4.
|
Bertolotto, C.,
R. Buscà,
P. Abbe,
K. Bille,
E. Aberdam,
J.-P. Ortonne, and R. Ballotti.
1998.
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia.
Mol. Cell. Biol.
18:694-702[Abstract/Free Full Text].
|
| 5.
|
Bertolotto, C.,
K. Bille,
J.-P. Ortonne, and R. Ballotti.
1996.
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
J. Cell. Sci.
134:747-755.
|
| 6.
|
Butt, J.,
J. Greenberg,
I. Winship,
S. Sellars,
P. Beighton, and R. Ramesar.
1994.
A splice junction mutation in PAX3 causes Waardenburg syndrome in a South African family.
Hum. Mol. Genet.
3:197-198[Free Full Text].
|
| 7.
|
Crouch, D. H.,
F. Fisher,
W. Clark,
P. S. Jayaraman,
C. R. Goding, and D. A. Gillespie.
1993.
Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Oncogene
8:1849-1855[Medline].
|
| 8.
|
Duttlinger, R.,
K. Manova,
G. Berrozpe,
T. Y. Chu,
V. DeLeon,
I. Timokhina,
R. S. Chaganti,
A. D. Zelenetz,
R. F. Bachvarova, and P. Besmer.
1995.
The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.
Proc. Natl. Acad. Sci. USA
92:3754-3758[Abstract/Free Full Text].
|
| 9.
|
Ferré-D'Amaré, A. R.,
P. Pognonec,
R. G. Roeder, and S. K. Burley.
1994.
Structure and function of the b/HLH/Z domain of USF.
EMBO J.
13:180-189[Medline].
|
| 10.
|
Fisher, F.,
D. H. Crouch,
P. S. Jayaraman,
W. Clark,
D. A. Gillespie, and C. R. Goding.
1993.
Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.
EMBO J.
12:5075-5082[Medline].
|
| 11.
|
Fisher, F., and C. R. Goding.
1992.
Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif.
EMBO J.
11:4103-4109[Medline].
|
| 12.
|
Galaktionov, K.,
X. Chen, and D. Beach.
1996.
CDC25 cell-cycle phosphatase as a target of c-myc.
Nature
382:511-517[Medline].
|
| 13.
|
Galibert, M.-D.,
L. Boucontet,
C. R. Goding, and T. Meo.
1997.
Recognition of the E-C4 element from the C4 complement gene promoter by the upstream stimulatory factor-1 transcription factor.
J. Immunol.
159:6167-6183.
|
| 14.
|
Ganss, R.,
G. Schutz, and F. Beermann.
1994.
The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements.
J. Biol. Chem.
269:29808-29816[Abstract/Free Full Text].
|
| 15.
|
Gardner, J. M.,
Y. Nakatsu,
Y. Gondo,
S. Lee,
M. F. Lyon,
R. A. King, and M. H. Brilliant.
1992.
The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes.
Science
257:1121-1124[Abstract/Free Full Text].
|
| 16.
| Goding, C. R., and J. Mellor. Unpublished
observations.
|
| 17.
|
Guthrie, C., and G. R. Fink.
1991.
Methods in enzymology, vol. 194. Guide to yeast genetics and molecular biology.
Academic Press, New York, N.Y.
|
| 18.
|
Hemesath, T. J.,
E. R. Price,
C. Takemoto,
T. Badalian, and D. E. Fisher.
1998.
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.
Nature
391:298-301[Medline].
|
| 19.
|
Hemesath, T. J.,
E. Steingrimsson,
G. McGill,
M. J. Hansen,
J. Vaught,
C. A. Hodgkinson,
H. Arnheiter,
N. G. Copeland,
N. A. Jenkins, and D. E. Fisher.
1994.
Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.
Genes Dev.
8:2770-2780[Abstract/Free Full Text].
|
| 20.
|
Hirst, K.,
F. Fisher,
P. C. McAndrew, and C. R. Goding.
1994.
The transcription factor, the Cdk, its cyclin and their regulator: directing the transcriptional response to a nutritional signal.
EMBO J.
13:5410-5420[Medline].
|
| 21.
|
Hodgkinson, C. A.,
K. J. Moore,
A. Nakayama,
E. Steingrimsson,
N. G. Copeland,
N. A. Jenkins, and H. Arnheiter.
1993.
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein.
Cell
74:395-404[Medline].
|
| 22.
|
Hosoda, K.,
R. E. Hammer,
J. A. Richardson,
A. G. Baynash,
J. C. Cheung,
A. Giaid, and M. Yanagisawa.
1994.
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice.
Cell
79:1267-1276[Medline].
|
| 23.
|
Jayaraman, P. S.,
K. Hirst, and C. R. Goding.
1994.
The activation domain of a basic helix-loop-helix protein is masked by repressor interaction with domains distinct from that required for transcription regulation.
EMBO J.
13:2192-2199[Medline].
|
| 24.
|
Lee, S. T.,
R. D. Nicholls,
M. T. Jong,
K. Fukai, and R. A. Spritz.
1995.
Organization and sequence of the human P gene and identification of a new family of transport proteins.
Genomics
26:354-363[Medline].
|
| 25.
|
Lowings, P.,
U. Yavuzer, and C. R. Goding.
1992.
Positive and negative elements regulate a melanocyte-specific promoter.
Mol. Cell. Biol.
12:3653-3662[Abstract/Free Full Text].
|
| 26.
|
Moore, K. J.
1995.
Insight into the microphthalmia gene.
Trends Genet.
11:442-448[Medline].
|
| 27.
|
Nakayama, A.,
M. T. Nguyen,
C. C. Chen,
K. Opdecamp,
C. A. Hodgkinson, and H. Arnheiter.
1998.
Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently.
Mech. Dev.
70:155-166[Medline].
|
| 28.
|
Nocka, K.,
S. Majumder,
B. Chabot,
P. Ray,
M. Cervone,
A. Bernstein, and P. Besmer.
1989.
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice.
Genes Dev.
3:816-826[Abstract/Free Full Text].
|
| 29.
|
O'Hare, P., and C. R. Goding.
1988.
Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation.
Cell
52:435-445[Medline].
|
| 30.
|
Opdecamp, K.,
A. Nakayama,
M. T. Nguyen,
C. A. Hodgkinson,
W. J. Pavan, and H. Arnheiter.
1997.
Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor.
Development
124:2377-2386[Abstract].
|
| 31.
|
Pingault, V.,
N. Bondurand,
K. Kuhlbrodt,
D. E. Goerich,
M.-O. Préhu,
A. Puliti,
B. Herbarth,
I. Hermans-Borgmeyer,
E. Legius,
G. Matthijs,
J. Amiel,
S. Lyonnet,
I. Ceccherini,
G. Romeo,
J. Clayton-Smith,
A. P. Read,
M. Wegner, and M. Goossens.
1998.
SOX10 mutations in patients with Waardenburgs-Hirschprung disease.
Nat. Genet.
18:171-173[Medline].
|
| 32.
|
Puffenberger, E. G.,
K. Hosoda,
S. S. Washington,
K. Nakao,
D. deWit,
M. Yanagisawa, and A. Chakravart.
1994.
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease.
Cell
79:1257-1266[Medline].
|
| 33.
|
Sato, S.,
K. Roberts,
G. Gambino,
A. Cook,
T. Kouzarides, and C. R. Goding.
1997.
CBP/p300 as a co-factor for the microphthalmia transcription factor.
Oncogene
14:3083-3092[Medline].
|
| 34.
|
Silvers, W. K.
1979.
The coat colors of mice.
Springer-Verlag, New York, N.Y.
|
| 35.
|
Solomon, D. L.,
B. Amati, and H. Land.
1993.
Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.
Nucleic Acids Res.
21:5372-5376[Abstract/Free Full Text].
|
| 36.
|
Southard-Smith, E. M.,
L. Kos, and W. Pavan.
1998.
Sox10 mutation disrupts neural crest development in Dom Hirschprung mouse model.
Nat. Genet.
18:60-64[Medline].
|
| 37.
|
Steingrímsson, E.,
K. J. Moore,
M. L. Lamoreaux,
A. R. Ferré-D'Amaré,
S. K. Burley,
D. C. Sanders Zimring,
L. C. Skow,
C. A. Hodgkinson,
H. Arnheiter,
N. G. Copeland, and N. A. Jenkins.
1994.
Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences.
Nat. Genet.
8:256-263[Medline].
|
| 38.
|
Tachibana, M.,
K. Takeda,
Y. Nobukuni,
K. Urabe,
J. E. Long,
K. A. Meyers,
S. A. Aaronson, and T. Miki.
1996.
Ectopic expression of MITF, a gene for Waardenburgs syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.
Nat. Genet.
14:50-54[Medline].
|
| 39.
|
Tassabehji, M.,
V. E. Newton, and A. P. Read.
1994.
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.
Nat. Genet.
8:251-255[Medline].
|
| 40.
|
Tsujimura, T.,
E. Morii,
M. Nozaki,
K. Hashimoto,
Y. Moriyama,
K. Takebayashi,
T. Kondo,
Y. Kanakura, and Y. Kitamura.
1996.
Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice.
Blood
88:1225-1233[Abstract/Free Full Text].
|
| 41.
|
Turque, N.,
F. Denhez,
P. Martin,
N. Planque,
M. Bailly,
A. Begue,
D. Stehelin, and S. Saule.
1996.
Characterization of a new melanocyte-specific gene (QNR-71) expressed in v-myc transformed quail neuroretina.
EMBO J.
15:3338-3350[Medline].
|
| 42.
|
Yasumoto, K.-I.,
K. Yokoyama,
K. Shibata,
Y. Tomita, and S. Shibahara.
1994.
Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.
Mol. Cell. Biol.
14:8058-8070[Abstract/Free Full Text].
|
| 43.
|
Yasumoto, K.-I.,
K. Yokayama,
K. Takahashi,
Y. Tomita, and S. Shibahara.
1997.
Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes.
J. Biol. Chem.
272:503-509[Abstract/Free Full Text].
|
| 44.
|
Yavuzer, U.,
E. Keenan,
P. Lowings,
J. Vachtenhein,
G. Currie, and C. R. Goding.
1995.
The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription.
Oncogene
10:123-134[Medline].
|
Molecular and Cellular Biology, December 1998, p. 6930-6938, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chiaverini, C., Beuret, L., Flori, E., Busca, R., Abbe, P., Bille, K., Bahadoran, P., Ortonne, J.-P., Bertolotto, C., Ballotti, R.
(2008). Microphthalmia-associated Transcription Factor Regulates RAB27A Gene Expression and Controls Melanosome Transport. J. Biol. Chem.
283: 12635-12642
[Abstract]
[Full Text]
-
Esumi, N., Kachi, S., Campochiaro, P. A., Zack, D. J.
(2007). VMD2 Promoter Requires Two Proximal E-box Sites for Its Activity in Vivo and Is Regulated by the MITF-TFE Family. J. Biol. Chem.
282: 1838-1850
[Abstract]
[Full Text]
-
Meadows, N. A., Sharma, S. M., Faulkner, G. J., Ostrowski, M. C., Hume, D. A., Cassady, A. I.
(2007). The Expression of Clcn7 and Ostm1 in Osteoclasts Is Coregulated by Microphthalmia Transcription Factor. J. Biol. Chem.
282: 1891-1904
[Abstract]
[Full Text]
-
Goding, C., Meyskens, F. L. Jr.
(2006). Microphthalmic-Associated Transcription Factor Integrates Melanocyte Biology and Melanoma Progression. Clin. Cancer Res.
12: 1069-1073
[Full Text]
-
Busca, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribere, L., Bertolotto, C., Virolle, T., Barbry, P., Pouyssegur, J., Ponzio, G., Ballotti, R.
(2005). Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J. Cell Biol.
170: 49-59
[Abstract]
[Full Text]
-
Vance, K. W., Carreira, S., Brosch, G., Goding, C. R.
(2005). Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas. Cancer Res.
65: 2260-2268
[Abstract]
[Full Text]
-
Corre, S., Primot, A., Sviderskaya, E., Bennett, D. C., Vaulont, S., Goding, C. R., Galibert, M.-D.
(2004). UV-induced Expression of Key Component of the Tanning Process, the POMC and MC1R Genes, Is Dependent on the p-38-activated Upstream Stimulating Factor-1 (USF-1). J. Biol. Chem.
279: 51226-51233
[Abstract]
[Full Text]
-
Planque, N., Raposo, G., Leconte, L., Anezo, O., Martin, P., Saule, S.
(2004). Microphthalmia Transcription Factor Induces Both Retinal Pigmented Epithelium and Neural Crest Melanocytes from Neuroretina Cells. J. Biol. Chem.
279: 41911-41917
[Abstract]
[Full Text]
-
Vetrini, F., Auricchio, A., Du, J., Angeletti, B., Fisher, D. E., Ballabio, A., Marigo, V.
(2004). The Microphthalmia Transcription Factor (Mitf) Controls Expression of the Ocular Albinism Type 1 Gene: Link between Melanin Synthesis and Melanosome Biogenesis. Mol. Cell. Biol.
24: 6550-6559
[Abstract]
[Full Text]
-
Szentirmay, M. N., Yang, H.-X., Pawar, S. A., Vinson, C., Sawadogo, M.
(2003). The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells. J. Biol. Chem.
278: 37231-37240
[Abstract]
[Full Text]
-
Du, J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Fisher, D. E.
(2003). MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma. Am. J. Pathol.
163: 333-343
[Abstract]
[Full Text]
-
Martinez-Morales, J. R., Dolez, V., Rodrigo, I., Zaccarini, R., Leconte, L., Bovolenta, P., Saule, S.
(2003). OTX2 Activates the Molecular Network Underlying Retina Pigment Epithelium Differentiation. J. Biol. Chem.
278: 21721-21731
[Abstract]
[Full Text]
-
Takemoto, C. M., Yoon, Y.-J., Fisher, D. E.
(2002). The Identification and Functional Characterization of a Novel Mast Cell Isoform of the Microphthalmia-associated Transcription Factor. J. Biol. Chem.
277: 30244-30252
[Abstract]
[Full Text]
-
Fang, D., Tsuji, Y., Setaluri, V.
(2002). Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res
30: 3096-3106
[Abstract]
[Full Text]
-
Jimenez-Cervantes, C., Martinez-Esparza, M., Perez, C., Daum, N., Solano, F., Garcia-Borron, J. C.
(2002). Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J. Cell Sci.
114: 2335-2344
[Abstract]
[Full Text]
-
Mansky, K. C., Marfatia, K., Purdom, G. H., Luchin, A., Hume, D. A., Ostrowski, M. C.
(2002). The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts. J. Leukoc. Biol.
71: 295-303
[Abstract]
[Full Text]
-
Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z., Fisher, D. E.
(2001). Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. USA
10.1073/pnas.091479298v1
[Abstract]
[Full Text]
-
Goding, C. R.
(2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev.
14: 1712-1728
[Full Text]
-
Kophengnavong, T., Michnowicz, J. E., Blackwell, T. K.
(2000). Establishment of Distinct MyoD, E2A, and Twist DNA Binding Specificities by Different Basic Region-DNA Conformations. Mol. Cell. Biol.
20: 261-272
[Abstract]
[Full Text]
-
Roundy, K., Kollhoff, A., Eichwald, E. J., Weis, J. J., Weis, J. H.
(1999). Microphthalmic Mice Display a B Cell Deficiency Similar to that Seen for Mast and NK Cells. J. Immunol.
163: 6671-6678
[Abstract]
[Full Text]
-
Boyd, K. E., Farnham, P. J.
(1999). Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells. Mol. Cell. Biol.
19: 8393-8399
[Abstract]
[Full Text]
-
Galibert, M.-D., Yavuzer, U., Dexter, T. J., Goding, C. R.
(1999). Pax3 and Regulation of the Melanocyte-specific Tyrosinase-related Protein-1 Promoter. J. Biol. Chem.
274: 26894-26900
[Abstract]
[Full Text]
-
Takeda, K., Yasumoto, K.-i., Takada, R., Takada, S., Watanabe, K.-i., Udono, T., Saito, H., Takahashi, K., Shibahara, S.
(2000). Induction of Melanocyte-specific Microphthalmia-associated Transcription Factor by Wnt-3a. J. Biol. Chem.
275: 14013-14016
[Abstract]
[Full Text]
-
Carreira, S., Liu, B., Goding, C. R.
(2000). The Gene Encoding the T-box Factor Tbx2 Is a Target for the Microphthalmia-associated Transcription Factor in Melanocytes. J. Biol. Chem.
275: 21920-21927
[Abstract]
[Full Text]
-
Lee, M., Goodall, J., Verastegui, C., Ballotti, R., Goding, C. R.
(2000). Direct Regulation of the Microphthalmia Promoter by Sox10 Links Waardenburg-Shah Syndrome (WS4)-associated Hypopigmentation and Deafness to WS2. J. Biol. Chem.
275: 37978-37983
[Abstract]
[Full Text]
-
Planque, N., Leconte, L., Coquelle, F. M., Martin, P., Saule, S.
(2001). Specific Pax-6/Microphthalmia Transcription Factor Interactions Involve Their DNA-binding Domains and Inhibit Transcriptional Properties of Both Proteins. J. Biol. Chem.
276: 29330-29337
[Abstract]
[Full Text]
-
Luchin, A., Suchting, S., Merson, T., Rosol, T. J., Hume, D. A., Cassady, A. I., Ostrowski, M. C.
(2001). Genetic and Physical Interactions between Microphthalmia Transcription Factor and PU.1 Are Necessary for Osteoclast Gene Expression and Differentiation. J. Biol. Chem.
276: 36703-36710
[Abstract]
[Full Text]
-
Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z., Fisher, D. E.
(2001). Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. USA
98: 5798-5803
[Abstract]
[Full Text]